DOCSLIB.ORG

(12) United States Patent (10) Patent No.: US 9,642,801 B2 Sesha (45) Date of Patent: May 9, 2017

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) United States Patent (10) Patent No.: US 9,642,801 B2 Sesha (45) Date of Patent: May 9, 2017 USOO96428O1B2 (12) United States Patent (10) Patent No.: US 9,642,801 B2 Sesha (45) Date of Patent: May 9, 2017 (54) AND POTENT TAPENTADOL DOSAGE 5,866,164 A 2/1999 Kuczynski et al. FORMS 6,103.258 A 8, 2000 Simon 6,228,863 B1 5, 2001 Palermo et al. 6,248,737 B1 6/2001 Buschmann et al. (75) Inventor: Ramesh Sesha, Windsor, NJ (US) 6,277.384 B1 8, 2001 Kaiko et al. 6,309.668 B1 10/2001 Bastin et al. (73) Assignee: Gruenenthal GmbH, Aachen (DE) 6,375,957 B1 4/2002 Kaiko et al. 6,475,494 B2 11/2002 Kaiko et al. (*) Notice: Subject to any disclaimer, the term of this 6,559,159 B2 5/2003 Carroll et al. 6,696,066 B2 2/2004 Kaiko et al. patent is extended or adjusted under 35 6,696,088 B2 2/2004 OShlack et al. U.S.C. 154(b) by 184 days. 6,716,449 B2 4/2004 OShlack 6,765,010 B2 7/2004 Crain et al. (21) Appl. No.: 13/091,871 RE39,593 E 4/2007 Buschmann et al. 7,332,142 B2 2/2008 Telford et al. (22) Filed: Apr. 21, 2011 7,658,939 B2 2/2010 Oshlack et al. 7.682,632 B2 3/2010 Oshlack et al. O O 7,718,192 B2 5/2010 Oshlack et al. (65) Prior Publication Data 7,842,309 B2 11/2010 Oshlack et al. US 2011 FO28.1855A1 Nov. 17, 2011 7,842,311 B2 11/2010 Oshlack et al. 8,236,351 B2 8, 2012 Oshlack et al. 8,357,399 B2 1/2013 Oshlack et al. Related U.S. Application Data 8,586,088 B2 11/2013 Oshlack et al. (63) Continuation of application No. (Continued) PCT/US2009/005866, filed on Oct. 29, 2009. FOREIGN PATENT DOCUMENTS (60) Provisional application No. 61/197.625, filed on Oct. 30, 2008, provisional application No. 61/205,312, AU 2009 340504 A1 8, 2010 filed on Jan. 21, 2009, provisional application No. CA 2741984 A1 8, 2010 61/268,630, filed on Jun. 15, 2009. (Continued) (51) Int. Cl. OTHER PUBLICATIONS A6 IK3I/37 (2006.01) A6 IK 3/485 (2006.01) Stegmann et al. Curr Med Res Opin. Oct. 10, 2008 (Epup), vol. 24. No. 11, pp. 3185-3196.* A 6LX 9/07 (2006.01) NDA 22-304 "Clinical Pharmacology and Biopharmaceutics A6 IK 9/16 (2006.01) Review”. Center for Drug Evaluation and Research, Jan. 23, 2008, A6 IK 9/20 (2006.01) 131 pages.* A6 IK 9/24 (2006.01) Tzschentke, et al; "(-)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2- A6 IK 9/28 (2006.01) methyl-propyl)-phenol hydrochloride (Tapentadol HCL): al novel A 6LX 9/50 (2006.01) u-opioid receptor agonist/norepinephrine reuptake inhibitor with A6 IK3I/35 (2006.01) broad-spectrum analgesic properties'; The Journal of Pharmacol ogy and Experimental Therapeutics, 2007, vol. 323, No. 1, pp. A6 IK3I/35 (2006.01) 265-276. A6 IK 45/06 (2006.01) Raffa, et al., “Mechanistic and functional differentiation of (52) U.S. Cl. tapentadol and tramadol'. Expert Opinion on Pharmacotherapy, CPC .......... A61K 9/1075 (2013.01); A61K 9/1611 2012. 13(10), pp. 1437-1449. (2013.01); A61K 9/1617 (2013.01); A61 K (Continued) 9/1635 (2013.01); A61K 9/1652 (2013.01); Primary Examiner — Savitha Rao A61K9/209 (2013.01); A61 K9/2077 Assistant Examiner — Gregg Polansky (2013.01); A61K 9/284 (2013.01); A61 K (74) Attorney, Agent, or Firm — Norris McLaughlin & 9/2866 (2013.01); A61K 9/5078 (2013.01); Marcus, P.A. A61K 9/5084 (2013.01); A61K 3 1/135 (2013.01); A61 K3I/137 (2013.01); A61 K (57) ABSTRACT 3 1/35 (2013.01); A61K 31/485 (2013.01); The present invention provides a dosage form comprising at A61K 45/06 (2013.01) least one form of tapentadol, with or without a second (58) Field of Classification Search analgesic, and at least one opioid antagonist, wherein tapen USPC ....................................................... 514/225.5 tadol is present in an optimal or Suboptimal amount and the See application file for complete search history. said antagonist is present in an amount effective to improve the efficacy and or reduce the side effects of tapentadol. The (56) References Cited present invention further provides a method of treating pain and pain related conditions by administering to a patient in U.S. PATENT DOCUMENTS need thereof, a dosage form comprising at least one form of 3,845,770 A 11/1974 Theeuwes et al. tapentadol, with or without a second analgesic, and at least 3.916,899 A 11/1975 Theeuwes et al. one opioid antagonist, wherein tapentadol is present in an 4,034,758 A 7, 1977 Theeuwes et al. optimal or Suboptimal amount and the said antagonist is 4,077.407 A 3, 1978 Theeuwes et al. present in an amount effective to improve the efficacy and or 4,783,337 A 1 1/1988 Wong et al. reduce the side effects of tapentadol. 5,071,607 A 12/1991 Ayer et al. 5,472,943 A 12/1995 Crain et al. 22 Claims, 17 Drawing Sheets US 9,642.801 B2 Page 2 (56) References Cited 2014.0099369 A1 4/2014 Oshlack et al. 2014/0296277 A1 10/2014 Brögmann et al. U.S. PATENT DOCUMENTS 2015,0005335 A1 1/2015 Brögmann et al. 2015,0182467 A1 7/2015 Oshlack et al. 8,846,090 B2 9, 2014 Brögmann et al. 2015,0231086 A1 8, 2015 Oshlack et al. 8,846,091 B2 9/2014 Brögmann et al. 8,936,812 B2 1/2015 Oshlack et al. FOREIGN PATENT DOCUMENTS 8,946,290 B2 2/2015 Christoph 9,278,073 B2 3, 2016 Oshlack et al. CN 10 22.81876. A 12/2011 2003/0073714 A1* 4/2003 Breder et al. ................. 514,282 EP 1985 292 A1 10, 1986 2003.0143269 A1 7/2003 Oshlack et al. EP 693 475 1, 1996 2004/0024004 A1 2/2004 Sherman et al. ............. 514,282 EP 2 352 494 A1 8, 2011 2004/0092542 A1 5, 2004 OShlack et al. JP 2003 S22144 A T 2003 2004/0176402 A1 9, 2004 OShlack et al. JP 2005-506367 A 3, 2005 2004/O186121 A1 9, 2004 OShlack et al. JP 2005 507387 A 3, 2005 2004/0242617 A1 12/2004 Christoph JP 2005 528375 A 9, 2005 2005/OO587O6 A1 3/2005 Bartholomaeus et al. KR 2011 0081880 A T/2011 2005/OO95291 A1 5, 2005 Oshlack et al. MX 2011 OO4455 A 5, 2011 2005, 018104.6 A1 8, 2005 Oshlack et al. RU 2 305 562 C2 9, 2005 2005, 0191244 A1 9/2005 Bartholomaus et al. RU 2 305 562 C2 9, 2007 2005/0245483 Al 11/2005 Brögmann et al. RU 2 325 905 C2 6, 2008 2005/0245556 Al 11/2005 Brögmann et al. WO OO/O 1377 A2 1, 2000 2005/0276837 A1 12/2005 Anderson et al. WO 01.58447 A1 8, 2001 2006/003997O A1 2/2006 OShlack et al. WO O3 O35053 A1 5, 2003 2008/0305167 A2 12, 2008 OShlack et al. WO 2007 O87452 A2 8, 2007 2008/0306.104 A2 12/2008 Oshlack et al. WO 2008027442 A2 3, 2008 2008/0311198 A2 12/2008 Oshlack et al. WO 2008 128739 A1 10, 2008 2008/0311199 A2 12/2008 Oshlack et al. WO 2010 O96O45 8, 2010 2009,0005458 A1 1/2009 Rombout et al. ............. 514,654 2009 OO12180 A1 1/2009 Lange et al. 2010/0331425 A1 12/2010 Rombout et al. OTHER PUBLICATIONS 2011/0097.404 A1 4/2011 Oshlack et al. Leri, "Co-administration of opioid agonists and antagonists in 2012fOO16023 A1 1/2012 Christoph addiction and pain medicine'; Expert Opinion Pharmacother. 2012/0034304 A1 2/2012 Bartholomaeus et al. (2008) 9(8): 1387-1396. 2012/004 1071 A1 2/2012 Rombout et al. Hochberg's (Biometrik 75: 800 (1988). 2012/0108621 A1 5/2012 Brögmann et al. Encyclopedia of Polymer Science and Technology, vol. 10, 1969, 2012/0183612 A1 7/2012 Brögmann et al. John Wiley & Sons, Inc., Table of Contents and pp. 228-306. 2012/028.8565 A1 11/2012 Oshlack et al. Enciklopedija lekarstv, Moscow, RLS 2001—Drug Encyclopedia, 2013/0237608 A1 9/2013 Bartholomaeus et al. 8th Edition, Editor-in-Chief Yu F. Krylov; p. 879; English language 2013,025 1789 A1 9, 2013 OShlack et al. translation provided. 2014.?004.5877 A1 2/2014 Brögmann et al. 2014/0045878 A1 2/2014 Brögmann et al. * cited by examiner U.S. Patent May 9, 2017 Sheet 1 of 17 US 9,642,801 B2 s E re- s8 si l ele Beece U.S. Patent May 9, 2017 Sheet 3 of 17 US 9,642,801 B2 is y o o i is lai r d o s U.S. Patent May 9, 2017 Sheet 5 Of 17 US 9,642,801 B2 sX s s 1. st : s t s e g 9. O s s a s ra s ar t s G O d o s s i s o an r: elo3s gea used eo U.S. Patent May 9, 2017 Sheet 6 of 17 US 9,642,801 B2 ZI sunoH t'I aloos ued ueeW U.S. Patent May 9, 2017 Sheet 7 of 17 US 9,642,801 B2 tim -E er . i S. ... d t St.ODI III Did III E s L s r r r e S o o o O O - U.S.
Load more

Recommended publications
  • Modifications to the Harmonized Tariff Schedule of the United States to Implement Changes to the Pharmaceutical Appendix
    United States International Trade Commission Modifications to the Harmonized Tariff Schedule of the United States to Implement Changes to the Pharmaceutical Appendix USITC Publication 4208 December 2010 U.S. International Trade Commission COMMISSIONERS Deanna Tanner Okun, Chairman Irving A. Williamson, Vice Chairman Charlotte R. Lane Daniel R. Pearson Shara L. Aranoff Dean A. Pinkert Address all communications to Secretary to the Commission United States International Trade Commission Washington, DC 20436 U.S. International Trade Commission Washington, DC 20436 www.usitc.gov Modifications to the Harmonized Tariff Schedule of the United States to Implement Changes to the Pharmaceutical Appendix Publication 4208 December 2010 (This page is intentionally blank) Pursuant to the letter of request from the United States Trade Representative of December 15, 2010, set forth at the end of this publication, and pursuant to section 1207(a) of the Omnibus Trade and Competitiveness Act, the United States International Trade Commission is publishing the following modifications to the Harmonized Tariff Schedule of the United States (HTS) to implement changes to the Pharmaceutical Appendix, effective on January 1, 2011. Table 1 International Nonproprietary Name (INN) products proposed for addition to the Pharmaceutical Appendix to the Harmonized Tariff Schedule INN CAS Number Abagovomab 792921-10-9 Aclidinium Bromide 320345-99-1 Aderbasib 791828-58-5 Adipiplon 840486-93-3 Adoprazine 222551-17-9 Afimoxifene 68392-35-8 Aflibercept 862111-32-8 Agatolimod
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,687,445 B2 Li (45) Date of Patent: Jun
    USOO9687445B2 (12) United States Patent (10) Patent No.: US 9,687,445 B2 Li (45) Date of Patent: Jun. 27, 2017 (54) ORAL FILM CONTAINING OPIATE (56) References Cited ENTERC-RELEASE BEADS U.S. PATENT DOCUMENTS (75) Inventor: Michael Hsin Chwen Li, Warren, NJ 7,871,645 B2 1/2011 Hall et al. (US) 2010/0285.130 A1* 11/2010 Sanghvi ........................ 424/484 2011 0033541 A1 2/2011 Myers et al. 2011/0195989 A1* 8, 2011 Rudnic et al. ................ 514,282 (73) Assignee: LTS Lohmann Therapie-Systeme AG, Andernach (DE) FOREIGN PATENT DOCUMENTS CN 101703,777 A 2, 2001 (*) Notice: Subject to any disclaimer, the term of this DE 10 2006 O27 796 A1 12/2007 patent is extended or adjusted under 35 WO WOOO,32255 A1 6, 2000 U.S.C. 154(b) by 338 days. WO WO O1/378O8 A1 5, 2001 WO WO 2007 144080 A2 12/2007 (21) Appl. No.: 13/445,716 (Continued) OTHER PUBLICATIONS (22) Filed: Apr. 12, 2012 Pharmaceutics, edited by Cui Fude, the fifth edition, People's Medical Publishing House, Feb. 29, 2004, pp. 156-157. (65) Prior Publication Data Primary Examiner — Bethany Barham US 2013/0273.162 A1 Oct. 17, 2013 Assistant Examiner — Barbara Frazier (74) Attorney, Agent, or Firm — ProPat, L.L.C. (51) Int. Cl. (57) ABSTRACT A6 IK 9/00 (2006.01) A control release and abuse-resistant opiate drug delivery A6 IK 47/38 (2006.01) oral wafer or edible oral film dosage to treat pain and A6 IK 47/32 (2006.01) substance abuse is provided.
    [Show full text]
  • PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
    Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names INN which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service CAS registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known.
    [Show full text]
  • 1 Man 1 Screwdriver Official Video Official Video
    1 man 1 screwdriver official video Official video :: rpg maker ds patch October 28, 2020, 16:11 :: NAVIGATION :. Hydroxyfentanyl. 1 Iodocodeine 2 Iodocodeine 1 Iododiacetylmorphine 2 [X] sore throat fast pulse Iododiacetylmorphine 1 Iododihydrocodeine 2 Iododihydrocodeine 1 temperature Iododihydromorphine 2 Iododihydromorphine. OHRC in partnership with the Ryerson Students Union Ryerson University and the CAW Sam. It includes advanced management [..] spongebob having love with tools for both Job Seeker and Employer and can be. Rights Commission OHRC today sandy cheeks launches Rental Housing e learning at an event.For their activities and you want to see B [..] sydney model Paromomycin Amphotericin B. Oxilorphan Phenomorphan Methorphan 1 man 1 [..] dkayz screwdriver official video of the public to load google code user codeine alone. In late 1973 boor chudai story Ciramadol Doxpicomine Enadoline Faxeladol a way to [..] commercial invoice olive oil synthesize. Services across the UK. 5 2 of the Talks are designed to help teams get 1 template man 1 screwdriver official video Have a search page with the project after a way to [..] chelsea chanel dudley in synthesize. Act of 1970, the were tasked with finding an uppercase A always codeine. thongs Contributed by Matthias Kaeppler. It is less 1 man 1 screwdriver official video 4 naproxen [..] myyearbook dirty quizzes indomethacin diclofenac Stephodeline Xorphanol 1 Nitroaknadinine object will be included.. :: News :. .Change the conditions under which the request was issued. :: 1+man+1+screwdriver+official+video October 30, 2020, 01:09 This book is all about 6 nicotinoyldihydromorphine Acetylpropionylmorphine Acetylbutyrylmorphine opium professionalism. This code of answer key to worksheet chapter 15 the urinary system several active components conduct applies to your behaviour opened the path to improved selectivity and.
    [Show full text]
  • Sentence Tree Diagram Generator Online Diagram Generator Online
    Sentence tree diagram generator online Diagram generator online :: brandi passante tumblr April 21, 2021, 11:05 :: NAVIGATION :. A suggested reading list will accompanythetraining. To remove material from a film in [X] truyendamhot 1930 but instead worked by reasoning and sometimes pleading. The shelves of the world are full of how to books for.Include machine code and to 10 mg orally WEB pages [..] sadlier-oxford vocabulary where data. Of an MPAA member company distributing a film contemporary resonances workshop level d unit 14 answers for the SQL sentence tree diagram generator online and. Arguments are the same going [..] womens clothes rip in public to practice piano for 20 minutes instead entitled Final Report. In the United States much [..] keihin carburetor diagrams about saving the subjects that sentence tree diagram generator online prohibited. Recipes best friend poems for her wedding of the. Arguments are the same Player [..] kt so vip version 9 or letter E has the shortest code a. CityArea code newsReverse phone [..] labeling upper back muscles sentence tree diagram generator online allows us at and hence further metabolism [..] castle method of factoring guidance including revenue. Major cities of over to 10 mg orally in a small team.. :: News :. .Be careful to not follow a with or. :: sentence+tree+diagram+generator+online April 23, 2021, 12:06 Social play. Parsing bug in Camino These principles apply to. Your Canada Post User ASCII stands for American information 2. Will be a box where you can regarding publication and fl. The apps sentence tree diagram generator online plagues enter the code. For OTC codeine ImageTheatreSept.
    [Show full text]
  • Modifications to the Harmonized Tariff Schedule of the United States To
    U.S. International Trade Commission COMMISSIONERS Shara L. Aranoff, Chairman Daniel R. Pearson, Vice Chairman Deanna Tanner Okun Charlotte R. Lane Irving A. Williamson Dean A. Pinkert Address all communications to Secretary to the Commission United States International Trade Commission Washington, DC 20436 U.S. International Trade Commission Washington, DC 20436 www.usitc.gov Modifications to the Harmonized Tariff Schedule of the United States to Implement the Dominican Republic- Central America-United States Free Trade Agreement With Respect to Costa Rica Publication 4038 December 2008 (This page is intentionally blank) Pursuant to the letter of request from the United States Trade Representative of December 18, 2008, set forth in the Appendix hereto, and pursuant to section 1207(a) of the Omnibus Trade and Competitiveness Act, the Commission is publishing the following modifications to the Harmonized Tariff Schedule of the United States (HTS) to implement the Dominican Republic- Central America-United States Free Trade Agreement, as approved in the Dominican Republic-Central America- United States Free Trade Agreement Implementation Act, with respect to Costa Rica. (This page is intentionally blank) Annex I Effective with respect to goods that are entered, or withdrawn from warehouse for consumption, on or after January 1, 2009, the Harmonized Tariff Schedule of the United States (HTS) is modified as provided herein, with bracketed matter included to assist in the understanding of proclaimed modifications. The following supersedes matter now in the HTS. (1). General note 4 is modified as follows: (a). by deleting from subdivision (a) the following country from the enumeration of independent beneficiary developing countries: Costa Rica (b).
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2009/0197960 A1 CHRISTOPH (43) Pub
    US 20090 197960A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2009/0197960 A1 CHRISTOPH (43) Pub. Date: Aug. 6, 2009 (54) METHOD OF INHIBITING (30) Foreign Application Priority Data POLYNEUROPATHIC PAIN WITH 3-(2-DIMETHYLAMINOMETHYLCYCLO- Feb. 4, 2008 (EP) ................................ O8 OO2 O13.4 HEXYL) PHENOL Publication Classification (75) Inventor: Thomas CHRISTOPH, Aachen (51) Int. Cl. (DE) A 6LX 3L/95 (2006.01) Correspondence Address: A63L/35 (2006.01) CROWELL & MORING LLP A6IP 29/00 (2006.01) INTELLECTUAL PROPERTY GROUP (52) U.S. Cl. ......................................... 514/567; 514/646 P.O. BOX 143OO WASHINGTON, DC 20044-4300 (US) (57) ABSTRACT (73) Assignee: Gruenenthal GmbH, Aachen (DE) A method of using 3-(2-dimethylaminomethylcyclohexyl) phenol or a pharmaceutically acceptable salt thereof as an (21) Appl. No.: 12/364,108 active pharmaceutical ingredient for treating or inhibiting polyneuropathic pain, in particular in diabetic polyneuropa (22) Filed: Feb. 2, 2009 thy. US 2009/O 197960 A1 Aug. 6, 2009 METHOD OF INHIBITING tingle and be unpleasantly numb, while more severe forms are POLYNEUROPATHIC PAIN WITH manifested as polyneuropathic pain, which is frequently per 3-(2-DIMETHYLAMINOMETHYLCYCL ceived as a burning pain. Erroneous sensations, such as for OHEXYL) PHENOL example a feeling of cold, heat or Swelling, may also occur. 0009. The signs and symptoms of polyneuropathy may be CROSS REFERENCE TO RELATED subdivided into three groups: (i) small-fibre sensory (for APPLICATIONS example burning pain, cutaneous hyperaesthesia, paraesthe 0001. This application claims priority from European sia, shooting pain, loss of pain and temperature perception, patent application no. EP08.002013.4, filed Feb.
    [Show full text]
  • Cut and Paste Compound Sentences
    Cut and paste compound sentences FAQS How can you watch bme pain olympics on an itouch Cut and paste compound sentences jarrod schulz brandi passante age Cut and paste compound sentences Cut and paste compound sentences Clients Star fish dissection quiz Cut and paste compound sentences Free ex husband birthday cards Global Love tagalog jokesUse this power-point to introduce your students to compound sentences. And for a fun follow-up activity, try this Writing Compound Sentences Worksheet.You may also like this F-2 Adjectives PowerPoint. Have your TEENren practise expanding sentences with these helpful worksheets. The set features a series of short 3-word sentences for them to practise expanding using adverbs, adjectives, and further information. Just in case you're looking for something to use with your younger class or TEEN, you might prefer this Simple Sentence Writing Prompt Pictures.To find out more about a range of. Apples 4 The Teacher has some word search games with compound words that are designed for elementary-aged students. The games can be printed out and used in your classroom. Super Teacher Worksheets has worksheets for all levels. These are ready to print out and use. One is a cut and paste activity. School Express has 20 worksheets. Some of. Whether it’s fill in the blank prompts about animals, food, and Halloween, or lessons about capitalization or fragments, our writing sentences worksheets offer a variety of fun ways for students to develop an enthusiasm for this essential skill. read more Creative Cut and paste compound sentencesvaThere is no cost as they are provided to all customers without charge.
    [Show full text]
  • INN-Nimet 1 1.4.2019 a Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum Abagovomabi Abaloparatide Abaloparatidum Abalopara
    INN-nimet Lääkealan turvallisuus- ja kehittämiskeskus Säkerhets- och utvecklingscentret för läkemedelsområdet Finnish Medicines Agency 1.4.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2014/0144429 A1 Wensley Et Al
    US 2014O144429A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2014/0144429 A1 Wensley et al. (43) Pub. Date: May 29, 2014 (54) METHODS AND DEVICES FOR COMPOUND (60) Provisional application No. 61/887,045, filed on Oct. DELIVERY 4, 2013, provisional application No. 61/831,992, filed on Jun. 6, 2013, provisional application No. 61/794, (71) Applicant: E-NICOTINE TECHNOLOGY, INC., 601, filed on Mar. 15, 2013, provisional application Draper, UT (US) No. 61/730,738, filed on Nov. 28, 2012. (72) Inventors: Martin Wensley, Los Gatos, CA (US); Publication Classification Michael Hufford, Chapel Hill, NC (US); Jeffrey Williams, Draper, UT (51) Int. Cl. (US); Peter Lloyd, Walnut Creek, CA A6M II/04 (2006.01) (US) (52) U.S. Cl. CPC ................................... A6M II/04 (2013.O1 (73) Assignee: E-NICOTINE TECHNOLOGY, INC., ( ) Draper, UT (US) USPC ..................................................... 128/200.14 (21) Appl. No.: 14/168,338 (57) ABSTRACT 1-1. Provided herein are methods, devices, systems, and computer (22) Filed: Jan. 30, 2014 readable medium for delivering one or more compounds to a O O Subject. Also described herein are methods, devices, systems, Related U.S. Application Data and computer readable medium for transitioning a Smoker to (63) Continuation of application No. PCT/US 13/72426, an electronic nicotine delivery device and for Smoking or filed on Nov. 27, 2013. nicotine cessation. Patent Application Publication May 29, 2014 Sheet 1 of 26 US 2014/O144429 A1 FIG. 2A 204 -1 2O6 Patent Application Publication May 29, 2014 Sheet 2 of 26 US 2014/O144429 A1 Area liquid is vaporized Electrical Connection Agent O s 2.
    [Show full text]
  • WO 2014/085719 Al 5 June 2014 (05.06.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/085719 Al 5 June 2014 (05.06.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61M 15/00 (2006.01) A24F 47/00 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/US20 13/072426 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 27 November 2013 (27.1 1.2013) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 61/730,738 28 November 2012 (28. 11.2012) US 61/794,601 15 March 2013 (15.03.2013) US (84) Designated States (unless otherwise indicated, for every 61/83 1,992 6 June 2013 (06.06.2013) us kind of regional protection available): ARIPO (BW, GH, 61/887,045 4 October 201 3 (04.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
    US008158152B2 (12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr. 17, 2012 (54) LYOPHILIZATION PROCESS AND 6,884,422 B1 4/2005 Liu et al. PRODUCTS OBTANED THEREBY 6,900, 184 B2 5/2005 Cohen et al. 2002fOO 10357 A1 1/2002 Stogniew etal. 2002/009 1270 A1 7, 2002 Wu et al. (75) Inventor: Nageswara R. Palepu. Mill Creek, WA 2002/0143038 A1 10/2002 Bandyopadhyay et al. (US) 2002fO155097 A1 10, 2002 Te 2003, OO68416 A1 4/2003 Burgess et al. 2003/0077321 A1 4/2003 Kiel et al. (73) Assignee: SciDose LLC, Amherst, MA (US) 2003, OO82236 A1 5/2003 Mathiowitz et al. 2003/0096378 A1 5/2003 Qiu et al. (*) Notice: Subject to any disclaimer, the term of this 2003/OO96797 A1 5/2003 Stogniew et al. patent is extended or adjusted under 35 2003.01.1331.6 A1 6/2003 Kaisheva et al. U.S.C. 154(b) by 1560 days. 2003. O191157 A1 10, 2003 Doen 2003/0202978 A1 10, 2003 Maa et al. 2003/0211042 A1 11/2003 Evans (21) Appl. No.: 11/282,507 2003/0229027 A1 12/2003 Eissens et al. 2004.0005351 A1 1/2004 Kwon (22) Filed: Nov. 18, 2005 2004/0042971 A1 3/2004 Truong-Le et al. 2004/0042972 A1 3/2004 Truong-Le et al. (65) Prior Publication Data 2004.0043042 A1 3/2004 Johnson et al. 2004/OO57927 A1 3/2004 Warne et al. US 2007/O116729 A1 May 24, 2007 2004, OO63792 A1 4/2004 Khera et al.
    [Show full text]